Pharmacology
News
Four commonly abused drugs linked with atrial fibrillation
All four drugs – cocaine, methamphetamine, opioids, and cannabis – whether stimulants or depressants – cause “quite dramatic and often rapid...
News
Durvalumab combinations show tentative promise in NSCLC
Phase 2 study indicates improved survival and objective response rate when combined with other immunotherapies.
News
FDA approves new immunotherapy combo for liver cancer
Conference Coverage
Drug repurposing ‘fast track’ to new medicines for obesity, diabetes
“We would like to progress some of these compounds to preclinical and clinical trials, but need to raise the funds for this expensive research.”...
News
JAK inhibitors show no excess cardiovascular safety signal in French nationwide cohort
Compared with adalimumab, JAK inhibitors presented no higher risk of major adverse cardiovascular events or venous thromboembolism in patients...
Conference Coverage
Nonhormonal drug fezolinetant found safe for hot flashes in yearlong study
Although additional safety studies await fezolinetant before it heads to the FDA for approval, it appears to be on its way to offering women an...
Conference Coverage
VTE prophylaxis overused in low-risk hospitalized patients
Better attention to a risk model could help determine the most appropriate type of VTE treatment, if needed.
News
Rapid point-of-care test could help avoid inappropriate antibiotic prescribing
A 10-minute fingerstick test failed to receive FDA clearance but has been okayed for sale outside the United States.
News
Apixaban outmatches rivaroxaban in patients with AFib and valvular heart disease
Compared with rivaroxaban, patients who received apixaban had a 43% reduced risk of stroke or embolism.
News
Self-worth training boosts ketamine’s effects in severe depression
The double-blind, randomized clinical trial is the first to assess combining ketamine with a low-cost protective learning program.